Skip to main content

NeuroStreet’s Series A Fundraising Round Fuels Injection Into Cutting Edge Trading Tech – Amidst Challenging Market Conditions

GetNews - Thu Mar 14, 8:12AM CDT

Ottawa, ON - March 14th, 2024 - NeuroStreet (, a trailblazer in the realm of trading education and fintech solutions, has achieved a remarkable feat by closing its Series A fundraising round during Q3 of 2023. This significant milestone was accomplished in less than six months, defying the bearish market sentiment prevailing during the period when many VC firms and lenders hesitated to deploy capital. The overwhelming support from investors underscores the unwavering confidence in NeuroStreet's vision and innovative product offerings.

The infusion of capital is set to propel NeuroStreet to new heights, fueling the advancement of its cutting-edge trading technology and heralding the creation of an unprecedented Hybrid Trading Platform. This strategic initiative is designed to empower traders worldwide with state-of-the-art tools and insights, equipping them to make more informed decisions and attain unparalleled success in the financial markets.

NeuroStreet has consistently been recognized for its dedication to delivering groundbreaking trading solutions and providing traders with the essential resources to thrive in a rapidly evolving market landscape. The funds raised in this transformative Series A round will accelerate NeuroStreet's mission to redefine trading technology and education.

Sean Kozak, CEO of NeuroStreet, expressed profound gratitude for the unwavering support and enthusiasm of the company's investors, stating, "Securing this substantial investment marks a pivotal moment for NeuroStreet. It allows us to expand our technological capabilities and embark on the creation of a truly revolutionary trading platform. At NeuroStreet, we are committed to empowering traders, and this fundraising round brings us significantly closer to realizing that vision."

Ashley Kozak, COO of NeuroStreet, added, "The financial markets are evolving at an unprecedented pace, and traders demand access to the latest tools and technologies to maintain their competitive edge. With this infusion of capital, we are poised to provide our clients with cutting-edge solutions that will set industry benchmarks."

Joshua Lombardo-Bottema, CRO of NeuroStreet, underscored the significance of this milestone, stating, "The success of this fundraising round is a testament to the unwavering trust our investors have in our vision. We are enthusiastic about embarking on this journey of innovation and eagerly anticipate unveiling our groundbreaking trading platform in the near future."

Jonathan Anderson, Advisor to NeuroStreet and CEO of Nothing Artificial Inc, the home of Neurotracker, said, "Our investor confidence in NeuroStreet and the success of our Series A financing empowers us to lead the charge into this new age of neuro and cognitive AI applied to trading. We are set to change the way the world trades by providing unparalleled tools and analytics."

With a legacy of consistently providing traders with the knowledge and tools they need to thrive, NeuroStreet is now poised for a quantum leap in technology development and can now cement its position as a vanguard in the trading industry.

For comprehensive insights into NeuroStreet and its portfolio of fin-tech brands, please visit

About NeuroStreet

NeuroStreet is a globally recognized fintech trading platform and education ecosystem of traders and investors.  With a collective sum of 50+ years in the trading tech and education space, we are proud to service traders, investors, prop firms, buy side & sell side firms.

Media Contact
Company Name:Otter PR
Contact Person: Thomas Mustac
Email:Send Email
Address:100 E Pine St Suite 110
City: Orlando
State: Florida
Country: United States

Press Release Distributed by
To view the original version on ABNewswire visit: NeuroStreet’s Series A Fundraising Round Fuels Injection Into Cutting Edge Trading Tech - Amidst Challenging Market Conditions

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

More from The Globe